ArticleESMO real world data and digital oncology2024

Real-world survival of patients treated with taxane therapy after exposure to immunotherapy and platinum-based chemotherapy for advanced non-small-cell lung cancer without actionable mutations.

S V Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.